Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Diana, González Bermejo"'
Autor:
Christian Llobera Ribera, María Teresa Ruiz-Cantero, Mar García-Calvente, Gemma Torrell, Diana González Bermejo, Carmen Olmedo, Emma Moatassim, Amaia Bacigalupe
Publikováno v:
Gaceta Sanitaria, Vol 38, Iss , Pp 102358- (2024)
Resumen: Objetivo: Profundizar desde la perspectiva de género en las lecciones aprendidas durante la pandemia de COVID-19 para hacer frente a futuras crisis de salud. Método: Estudio con informantes clave con experiencia en salud pública y género
Externí odkaz:
https://doaj.org/article/5dc8c97a90eb448bacaf0007a6a7b7ae
Autor:
Rasha Alqdwah-Fattouh, Sara Rodríguez-Martín, Diana Barreira-Hernández, Laura Izquierdo-Esteban, Miguel Gil, Diana González-Bermejo, Encarnación Fernández-Antón, Antonio Rodríguez-Miguel, Alberto García-Lledó, Francisco Bolúmar, Francisco J. de Abajo
Publikováno v:
Stroke. 53:1560-1569
Background: Multiple studies have reported that the use of selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of ischemic stroke; however, this finding may be the result of a confounding by indication. We examined th
Autor:
Consuelo Huerta-Alvarez, Belén Castillo-Cano, Arturo Álvarez-Gutiérrez, Mª Félix García-Martín, Diana González-Bermejo, Alfonso Rodríguez-Pascual, Dolores Montero-Corominas
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:294-301
Background Liver injury is an important identified risk for agomelatine and several measures were put in place to prevent and minimize such risk. The study aims to assess the impact of four interventions on the incidence of agomelatine use, particula
Autor:
Diego Macías Saint Gerons, César de la Fuente Honrubia, Diana González Bermejo, Dolores Montero, Miguel J. Gil, Antonio Salvador Sanz, Fernando de Andrés Trelles, Ferrán Catalá López
Publikováno v:
Revista Española de Salud Pública, Vol 89, Iss 2, Pp 159-171 (2015)
Las nuevas recomendaciones respecto a la utilización de estatinas potentes y/o dosis altas (terapia intensiva) para el tratamiento de la enfermedad cardiovascular se han basado en la extrapolación de los resultados de los ensayos clínicos. El obje
Externí odkaz:
https://doaj.org/article/1fe8456230064ddd97c132c0a04e1c72
Autor:
Diana, González Bermejo, Almudena, López-Fando Santafé, Ana, Fernández Dueñas, Dolores, Montero Corominas, Consuelo, Huerta Álvarez
Publikováno v:
Revista espanola de salud publica. 96
Non-inferiority studies are increasingly more common for introducing new medicines in the market. Despite being situations where the use of this study design is justified, there is not a common analytical approach on how to conduct them. Pursuing a r
Autor:
Maria Pilar Vicente Sánchez, Diego Macías Saint-Gerons, Diana González Bermejo, Dolores Montero Corominas, Ferrán Catalá-López, César de la Fuente Honrubia
Publikováno v:
Revista Española de Salud Pública, Vol 87, Iss 3, Pp 247-255 (2013)
de los grupos farmacológicos más prescritos en la mayoría de países des- arrollados. El objetivo principal del presente trabajo fue explorar el patrón de uso de ansiolíticos e hipnóticos en España durante el período 2000-2011 y comparar su i
Externí odkaz:
https://doaj.org/article/3aad50eb125646d58461daa66be4ee96
Autor:
Ferrán Catalá-López, Diego Macías Saint-Gerons, Diana González-Bermejo, Giuseppe M Rosano, Barry R Davis, Manuel Ridao, Abel Zaragoza, Dolores Montero-Corominas, Aurelio Tobías, César de la Fuente-Honrubia, Rafael Tabarés-Seisdedos, Brian Hutton
Publikováno v:
PLoS Medicine, Vol 13, Iss 3, p e1001971 (2016)
BackgroundMedications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. W
Externí odkaz:
https://doaj.org/article/cb0fbec97c0c4a97b964cd1d790684be
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication
Autor:
Arturo Álvarez-Gutiérrez, Ana Fernández-Dueñas, Diana González-Bermejo, Consuelo Huerta-Alvarez, Dolores Montero-Corominas, Pilar Rayón-Iglesias, Alfonso Rodríguez-Pascual
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:371-378
PURPOSE: We aimed to characterize the trends of immediate release fentanyl (IRF) use in Spain between 2012 and 2017 and indication for its use. IRF drugs are rapid-acting opioids approved to treat breakthrough cancer pain (BTCP) in patients already r
Autor:
Sara Rodríguez-Martín, Francisco Bolumar, Rasha Alqdwah-Fattouh, Alberto García-Lledó, Miguel Gil, Francisco J. de Abajo, Diana González-Bermejo
Publikováno v:
Br J Clin Pharmacol
The primary objective of this study was to investigate the association between antidepressants use and the risk of acute myocardial infarction (AMI). METHODS: We conducted a nested case–control study using a primary care database over the period 20
Autor:
Miguel Gil, Diana Barreira-Hernández, Diana González-Bermejo, Ramón Mazzucchelli, Sara Rodríguez-Martín, Alberto García-Lledó, Antonio Rodríguez-Miguel, Francisco J. de Abajo, Luis A. García-Rodríguez
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 12
Volume 8
Issue 12
Objectives: To test the hypothesis that allopurinol reduces the risk of acute myocardial infarction (AMI) in hyperuricemic patients and to assess whether the effect is dependent on dose, duration and serum uric acid (SUA) level attained after treatme